Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 54 (2023)
Retraction Note: J Exp Clin Cancer Res 40, 299 (2021)
The Editor in Chief has retracted this article. After publication, concerns were raised about an apparent partial overlap between the leftmost SNU-449 migration panel in Fig. 2C and the top LNCAROD+2-DG panel in Fig. 4G. The authors were unable to provide a satisfactory set of raw data on request. Additionally, the issues regarding the provenance of cell lines were not completely resolved in the published version of the article. The editor, therefore, has lost confidence in the integrity of the findings of this article. The authors have not explicitly stated that they agree to this retraction.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Jia, G., Wang, Y., Lin, C. et al. Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. J Exp Clin Cancer Res 42, 54 (2023). https://doi.org/10.1186/s13046-023-02626-z